Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Benjamin Hohl Insider Profile
4 Followers
Benjamin Hohl, CFO at Enliven Therapeutics, holds 0.00 shares in Enliven Therapeutics (Ticker: ELVN).
Benjamin Hohl has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Benjamin Hohl does not currently own shares as a corporate insider.
A breakdown of Benjamin Hohl's holdings
Insider Roles
CFO
Roles that Benjamin Hohl holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Benjamin Hohl
Benjamin Hohl's Trading History
List of latest transactions for each holding click on a transaction to see Benjamin Hohl's performance on stock
You May Also Like
Benjamin Hohl insider profile FAQ
What is the percentage of profitable transactions made by Benjamin Hohl?
The percentage of profitable transactions made by Benjamin Hohl is ―.
What is the average return per transaction made by Benjamin Hohl?
The average return per transaction made by Benjamin Hohl is ―.
What stocks does Benjamin Hohl hold?
Benjamin Hohl holds: ELVN stocks.
What was Benjamin Hohl’s latest transaction?
Benjamin Hohl latest transaction was an Uninformative Buy of $13.02K.
What was Benjamin Hohl's most profitable transaction?
Benjamin Hohl’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Benjamin Hohl's role in Enliven Therapeutics?
Benjamin Hohl's role in Enliven Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.